Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CACNA1H | O95180 | 8/20 | 0.40 |
| ▸ | CYP11B2 | P19099 | 8/20 | 0.40 |
| ▸ | CYP11B1 | P15538 | 7/20 | 0.40 |
| ▸ | CPB2 | Q96IY4 | 1/20 | 0.40 |
| ▸ | DAO | P14920 | 2/20 | 0.39 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7743300 | 0.80 | CPB2 (0.48) | CACNA1HCYP11B2CYP11B1CPB2DAO | |
| SCHEMBL7704752 | 0.77 | DAO (0.40) | CACNA1HCYP11B2CYP11B1DAO | |
| SCHEMBL7743898 | 0.76 | CPB2 (0.62) | CPB2DAOCYP19A1 | |
| Lithium Ion SCHEMBL7743896 | 0.75 | CPB2 (0.50) | CACNA1HCYP11B2CYP11B1CPB2DAO | |
| SCHEMBL13542855 | 0.74 | CYP3A4 (0.47) | CACNA1HCYP11B2CYP11B1DAO | |
| SCHEMBL28578973 | 0.71 | TRPV4 (0.45) | CACNA1HCYP11B2CYP11B1DAO | |
| SCHEMBL6432281 | 0.67 | DAO (0.42) | CACNA1HCYP11B2CYP11B1DAO | |
| SCHEMBL31605567 | 0.66 | TRPV4 (0.52) | CYP11B2CYP11B1DAO | |
| SCHEMBL16892292 | 0.66 | TRPV4 (0.52) | CYP11B2CYP11B1DAO | |
| Bromide SCHEMBL6409244 | 0.66 | DAO (0.42) | CACNA1HCYP11B2CYP11B1DAO |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6358985-B1 | ANTICANCER AGENT | MERCK & CO., INC. | 2002-03-19 | — | — | US | disclosed |